Back to Locations

Indiana University Cancer Center

Indiana Cancer Pavilion - Indianapolis, IN 46202
Website: http://cancer.iu.edu

For information about clinical trials being conducted in Indianapolis, IN, please contact Kerry Bridges at 317.274.2552.


Lawrence Einhorn, MD (Principal Investigator)

Trials at this Location:


Disease: Breast
A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer - BRE12-158
Status: Open to Accrual 03/26/2014
More Details
Disease: Bladder
Phase II Trial of Everolimus or Everolimus plus Paclitaxel as First-line Therapy in Cisplatin-ineligible Patients with Advanced Urothelial Carcinoma: Hoosier Oncology Group GU10-147 - GU10-147
Status: Open
More Details
Disease: Bladder
Phase II Trial of Gemcitabine, Cisplatin, plus Ipilimumab as First-line Treatment for Patients with Metastatic Urothelial Carcinoma - GU10-148
Status: Opened Feb 2012
More Details
Disease: Bladder
Phase II Trial of Dovitinib in BCG-Refractory Urothelial Carcinoma Patients with Tumor FGFR3 Mutations or Over-expression - GU12-157
Status: Opened 3/3/2013
More Details
Disease: Prostate
A Randomized Phase II Study Evaluating OGX-427 in Patients with Metastatic Castrate-Resistant Prostate Cancer Who Have PSA Progression While Receiving Abiraterone - GU12-159
Status: Opened 2/13/2013
More Details
Disease: Bladder
A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum Regimen - GU12-160
Status: Open 4/30/2013
More Details
Disease: Ovarian
A Phase I-II Clinical Trial of Pegylated Liposomal Doxorubicin (Doxil®) in Combination with BIBF 1120 in Patients with Ovarian Cancer: Hoosier Oncology Group GYN10-149 - GYN10-149
Status: SUSPENDED 11/12/2013. Opened 11/29/2011
More Details
Disease: Multiple Myeloma
A Phase I/II trial of Bendamustine in Combination with Bortezomib and Pegylated Liposomal Doxorubicin (Doxil) in Patients with Relapsed or Refractory Multiple Myeloma - MM08-141
Status: SUSPENDED 11/4/2013. Open to Accrual 03/05/2010
More Details
Disease: Quality Of Life
Phase II study of Fosaprepitant + 5HT3 receptor antagonists + Dexamethasone in patients with germ cell tumors undergoing 5 day Cisplatin based chemotherapy - QL12-153
Status: Opened 12/19/2012
More Details